Mukul Agrawal buys stake in this underperforming IPO, sends stock soaring

The latest shareholding pattern for the June quarter showed that veteran investor Mukul Agrawal has acquired a 1.28% stake in Tatva Chintan Pharma during the April – June period.

Leave a Reply

Your email address will not be published. Required fields are marked *